Tyler Stone Wealth Management Moderna, Inc. Transaction History

Tyler Stone Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $7,256 - $9,812	-85 Reduced 16.5%	430 $45,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2,780 - $4,177	40 Added 8.42%	515 $51,000
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $11,713 - $17,659	-100 Reduced 17.39%	475 $68,000
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $27,188 - $50,535	215 Added 59.72%	575 $99,000
Q4 2021 Feb 22, 2022	BUY	$225.82 - $368.51 $81,295 - $132,663	360 New	360 $91,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Tyler Stone Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Tyler Stone Wealth Management with notifications on news.